ASST Fatebenefratelli-Sacco Ospedale Luigi Sacco — Milan

Public research footprint of ASST Fatebenefratelli-Sacco Ospedale Luigi Sacco, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

HIV -1 Infection · Geographic Atrophy Secondary to Age-related Macular Degeneration · Hereditary Angioedema (HAE) · PrEP Adherence Monitoring

Recently updated registry entries

NCT04770545 — An Extension Study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan (APL-2)… (Completed)
NCT05300724 — An Observational Study of the Progression of Intermediate Age-Related Macular Degeneration (Active Not Recruiting)
NCT07015190 — Neoadjuvant Darovasertib in Primary Uveal Melanoma (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at ASST Fatebenefratelli-Sacco Ospedale Luigi Sacco?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.